Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: J Org Chem. 2007 Aug 14;72(19):7451–7454. doi: 10.1021/jo071132e

Total Synthesis of Pumiliotoxins 209F and 251D via Late-Stage, Nickel-Catalyzed Epoxide-Alkyne Reductive Cyclization

Katrina S Woodin 1, Timothy F Jamison 1,*
PMCID: PMC3148183  NIHMSID: NIHMS308280  PMID: 17696401

Abstract

graphic file with name nihms308280u1.jpg

Pumiliotoxins 209F and 251D were synthesized using highly selective nickel-catalyzed epoxide-alkyne reductive cyclizations as the final step. The exocyclic (Z)-alkene found in the majority of the pumiliotoxins was formed stereospecifically and regioselectively, without the use of a directing group on the alkyne, and the epoxide underwent ring opening exclusively at the less hindered carbon to provide the requisite tertiary alcohol. The epoxides were prepared using diastereoselective addition of a sulfoxonium anion to a proline-derived methyl ketone.


The pumiliotoxins were first isolated in 1967 from the Dendrobates pumilio frogs in South America.i,ii The structure and stereochemistry of these alkaloids were initially established via X-ray crytallographic analysis of the hydrochloride salt of pumiliotoxin 251D (1)iii and confirmed by total syntheses of several members of this family of natural products.iv,v,vi,vii Thirty pumiliotoxins have a (Z)-6-alkylideneindolizidine ring system and a tertiary alcohol at C8.

Several different strategies have been developed for the synthesis of the ubiquitous (Z)-alkene. Overman used an iminium ion-vinylsilane cyclization to this end in the first total synthesis of pumiliotoxin 251D6a and later employed a related iodide-promoted, iminium ion-alkyne cyclization to synthesize more complex pumiliotoxins.4,viii Gallagher used a stereospecific elimination of a β-hydroxylactam to install the (Z)-alkene in the synthesis of pumiliotoxin 251D.6b In the synthesis described herein, we have reduced the construction of the pumiliotoxins to simultaneous and stereospecific installation of the exocyclic Z-alkene and tertiary alcohol present in the final step of the synthesis.

Our strategy is based on the notion that both of these challenges could be addressed by nickel-catalyzed reductive cyclizationsix of epoxy-alkynes previously developed in our laboratory (Figure 1).x However, all of the epoxides in our earlier investigations were monosubstituted (terminal). Thus a major question in the context of the pumiliotoxins was whether or not 1,1-disubstituted epoxides (e.g., 3a and 3b), which we had previously found to be recalcitrant substrates, would undergo reductive cyclization.xi Furthermore, in order to be used as the final step, the regioselectivity of both alkyne addition and epoxide ring-opening could not depend upon the use of a directing group on the alkyne. Nevertheless, proline-derived ketones 4a and 4b and propargyl bromides 5a and 5b were attractive precursors and readily available. Accordingly, we began our investigations by preparing these intermediates via chiral ketones 4a and 4b.

Figure 1.

Figure 1

Retrosynthetic Analysis of the Pumiliotoxins.

Treatment of carbamate-protected proline methyl esters 6a and 6bxii with N,O-dimethylhydroxylamine hydrochloride and trimethylaluminium afforded Weinreb amides 7a and 7b, respectively, in good yield (Scheme 1). Conversion of these amides to ketones 4a and 4b proceeded in a similarly straightforward manner, setting the stage for investigation of the step that would set the stereogenic center corresponding to the tertiary alcohol in the natural products.xiii

Scheme 1.

Scheme 1

Synthesis of Proline-Derived Ketone 4

Application of the Corey-Chaykovskyxiv sulfur-ylide epoxidation method provided stereochemically complementary results, depending on which sulfonium reagent was employed.xv When Cbz-protected ketone 4a was subjected to dimethylsulfonium methylide, the undesired diastereomer (epoxide 8a) was formed with high selectivity (>10:1 dr) in good yield, but both diastereomers were optically inactive, suggesting rapid racemization of the proline-derivative prior to a highly diastereoselective epoxide formation. Gratifyingly, when dimethyloxosulfonium methylide was used, the desired diastereomer (8a) was afforded in good yield and in a highly diastereoselective fashion (>10:1 dr). It was further discovered that the carbamate group was required to impart the high diastereoselectivity during the epoxidation, as other proline-derived ketones gave a 1:1 mixture of diastereomers.xvi The dimethylsulfonium methylide reagent often exhibits kinetic control of stereoselectivity. In a Felkin-Ahn analysis of the reaction at hand, the nucleophile would approach anti to the carbamate group, leading to the observed diastereomer (8a, undesired). Conversely, diastereoselective dimethylsulfoxonium methylide addition reactions tend to be under thermodynamic control. Epoxide 8a (desired) may thus be favored under these conditions because of the reversible nature of the addition process and a greater thermodynamic stability of either a subsequent intermediate or of 8a itself.xvii

Attempts to remove the Cbz group from epoxide 8a unfortunately led to a complex mixture of products under all conditions evaluated. We thus turned our attention to the Alloc series and found that the conditions that provided high dr in the Cbz series (NaH, trimethylsulfoxonium chloride) gave similar results with Alloc-protected ketone 4b. However, although the desired product had formed with high diastereoselectivity, it was optically inactive, suggesting that racemezation of ketone 4b had occurred prior to the epoxidation. A careful examination of reagents and reaction conditions revealed that the racemization could be prevented by the use of n-BuLi (instead of NaH) at a lower reaction temperature (Scheme 3).xviii This sequence provided epoxide 8b with high diastereoselectivity and optical purity. Removal of the Alloc group was effected with catalytic Pd(dba)2 and dppb in the presence of excess diethylamine.xix The free amine was treated with propargyl bromide 5axx (Na2CO3/acetone) to form epoxy-alkyne 3a, thus setting the stage for the critical nickel-catalyzed step.

Scheme 3.

Scheme 3

Synthesis of Epoxy-Alkyne 3a (209F Precursor)

Under reaction conditions routinely used in intermolecular nickel-catalyzed coupling reactions between alkynes and terminal epoxides,9 no conversion of epoxy-alkyne substrate 3a was observed (Table 1, entry 1). However, conducting the reaction in the absence of an additional solvent did lead to the formation of small amounts of the desired product, pumiliotoxin 209F (2). The largest increase in yield was imparted by conducting the reaction at slightly elevated temperature (entry 3). By lowering the amount of Et3B to 150 mol%, which also considerably increased the concentration of the reaction, the yield appreciated further (entry 4). The phosphine employed also had a dramatic effect on the yield. The larger tricyclopentylphosphine (PCyp3) was inferior to tributylphosphine (PBu3), and the smaller PMe2Ph was superior to all phosphines evaluated (entries 5 and 6). xxi,xxii,xxiii Under the optimum conditions the nickel-catalyzed reductive cyclization of epoxy-alkyne 2a proceeded in 70% yield to produce pumiliotoxin 209F (2).

Table 1.

Synthesis of Pumiliotoxin 209F via Nickel-Catalyzed Reductive Cyclizationa

graphic file with name nihms308280u2.jpg
entry solvent added T (°C) Et3B (mol%) phosphine additive isolated yield (%)
1 Et2O 23 250 PBu3 0
2 none 9
3 65 53
4 150 61
5 PCyp3 0
6 PMe2Ph 70
a

See Supporting Information for experimental details.

In addition to representing the first example of a successful nickel-catalyzed cyclization between a 1,1-disubstituted epoxide and an alkyne, a noteworthy element of selectivity was that the six-membered ring was formed exclusively. The other alkyne addition regioisomer would have led to a seven-membered ring containing an alkene. This isomer was not observed, likely because cis addition to the alkyne, a process that occurs with very high fidelity, would lead to a highly strained trans alkene in the seven-membered ring as the carbon-carbon bond formed. In a similar vein, no evidence of epoxide opening at the more hindered carbon, which would lead to a five-membered ring, was observed. We believe that the sense of epoxide-opening regioselectivity is largely dictated by this difference in steric hindrance, and it is also possible that the Ni complex reacts with the epoxide first, which in turn classifies addition to the alkyne as a 6-exo-dig cyclization.x

To investigate the utility and scope of this cyclization further and to take advantage of the high degree of convergence in this strategy, pumiliotoxin 251D (1) was also synthesized. Substitution of the appropriate propargyl electrophile for 5a (Scheme 3) would provide the necessary educt for the nickel-catalyzed reductive cyclization. In other words, after preparation of propargyl bromide 5b,xxiv only two new transformations would be required to convert a known intermediate in the 209F synthesis to pumiliotoxin 251D.

The route to pumiliotoxin 251D thus began with synthesis of alcohol 10 from aldehyde 9xxv using the Corey-Fuchs reaction (Scheme 4).xxvi This alcohol was converted to bromide 5b, and epoxide 3b was afforded by alkylation of the primary amine prepared previously.

Scheme 4.

Scheme 4

Synthesis of Epoxy-Alkyne 3b (251D Precursor)

As was the case in the pumiliotoxin 209F studies, the final step of the 251D synthesis, nickel-catalyzed reductive cyclization of epoxy-alkyne 3b proceeded smoothly, affording the natural product in 82% yield as a single diastereomer and regioisomer (Scheme 5).

Scheme 5.

Scheme 5

Synthesis of Pumiliotoxin 251D via Nickel-Catalyzed Reductive Cyclization

In summary, pumiliotoxin 209F was synthesized in seven steps (longest linear sequence) in 25% overall yield, and pumiliotoxin 251D was synthesized in nine linear steps from commercial materials in 17% overall yield. Both syntheses utilized a novel cyclization reaction, an intramolecular, nickel-catalyzed reductive coupling of a 1,1-disubstituted epoxide and an alkyne. In this way the tertiary homoallylic alcohol and exocyclic trisubstituted alkene moieties present in this family of natural products were prepared in the final step of each total synthesis. For these reasons, this strategy shows promise for entry into other members of the pumiliotoxin family by way of a common intermediate.

Experimental Section

(S)-Allyl 2-((R)-2-methyloxiran-2-yl)pyrrolidine-1-carboxylate (8b)

Me3SOCl (0.096 g, 0.75 mmol) was dissolved in THF (7 mL) and nBuLi (0.22 mL, 0.55 mmol, 2.5M in hexanes) was added dropwise at rt. The reaction was stirred at rt for 4.5 h, then cooled to −20 °C and the slurry was added to the ketone 4b (0.099 g, 0.5 mmol), dissolved in THF (2 mL), dropwise via cannula over 20 min. The reaction was stirred at −20 °C for 32 h and quenched with 0.1 M NaHSO4 (10 mL).7 The aqueous layer was extracted with ethyl acetate (3 × 10 mL), and the organic extracts were washed with brine (50 mL), and dried over Na2SO4. The solution was filtered and concentrated in vacuo, and was purified by flash column chromatography (3:7 EtOAc:hexanes) to give alloc-protected epoxide 8b (0.076 g, 72% yield, 91:9 dr favoring desired diastereomer, >98% ee, as determined by chiral GC). Rf 0.41 (1:1 EtOAc:hexanes). 1H NMR (500 MHz, CDCl3) (reported as ~1:1 mixture of rotamers) δ 5.97–5.90 (m, 2H), 5.31 (dd, J = 10.4, 1.1 Hz, 2H), 5.20 (dd, J = 10.4, 1.1 Hz, 2H), 4.68–4.52 (m, 4H), 4.06 (d, J = 6.4 Hz, 1H), 3.94 (d, J = 6.4 Hz, 1H), 3.62–3.28 (m, 4H), 2.63 (d, J = 4.6 Hz, 2H), 2.53 (d, J = 4.6 Hz, 2H), 2.10–1.67 (m, 8H), 1.35 (s, 3H), 1.33 (s, 3H). 13C NMR (125 MHz, CDCl3) (reported as ~1:1 mixture of rotamers) δ 155.6, 155.3, 133.3, 117.5, 117.4, 65.9, 59.5, 59.0, 52.6, 52.4, 47.7, 47.2, 29.0, 27.8, 24.6, 23.9, 19.9, 19.6. IR (thin film NaCl) 3057, 2980, 2882, 1702, 1648, 1405, 1350, 1335, 1277, 1186, 1121, 1098, 919, 774 cm−1. HRMS (ESI) m/z 234.1105 [M+Na; calcd for C11H17NO3: 234.1101]. [α]D = −80.8 (23 °C, 589 nm, 0.45 g/100 mL, CHCl3).

(S)-2-((R)-2-methyloxiran-2-yl)-1-(4-methylpent-2-ynyl)pyrrolidine (3a)

Pd(dba)2 (0.086 g, 0.15 mmol) and dppb (0.064 g, 0.15 mmol) were combined in a glove box. Alloc-protected epoxide 8b (0.317 g, 1.5 mmol) in THF (4 mL) was added followed by addition of diethylamine (2.3 mL, 22.5 mmol). The reaction was stirred at rt for 2 h, then filtered through a plug of celite with ether (10 mL) to removed the palladium catalyst and was concentrated in vacuo to form free amine. The amine was dissolved in acetone (15 mL) and Na2CO3 (0.398 g, 3.75 mmol) and propargyl bromide 5a (0.290 g, 1.8 mmol) were added, and the reaction was allowed to stir at rt for 16 h. The solvent was removed in vacuo, and the compound was purified by flash column chromatography using a solvent gradient (1:19 to 3:7 EtOAc:hexanes) to give amine 3a as a pale yellow oil (0.17 g, 55% yield over the two steps, 91:9 dr retained). Rf 0.51 (1:1 EtOAc:hexanes). 1H NMR (500 MHz, CDCl3) (reported as a 10:1 mixture of diastereomers, asterisk denotes minor diastereomer): δ 3.60 (dd, J = 16.7, 1.9 Hz, 1H), 3.49* (dd, J = 16.7, 1.9 Hz, 0.1H), 3.41* (dd, J = 16.7, 1.9 Hz, 0.1H), 3.31 (dd, J = 16.7, 1.9 Hz, 1H), 3.08 (t, J = 7.3 Hz, 1H), 2.96* (t, J = 7.3 Hz, 0.1H), 2.77* (d, J = 5.3 Hz, 0.1H), 2.62–2.48 (m, 4H), 2.27 (t, J = 7.33 Hz, 1H), 1.89–1.70 (m, 4H), 1.33 (s, 3H), 1.29* (s, 0.3H), 1.60 (d, J = 6.9 Hz, 6H) 1.15* (d, J = 6.9 Hz, 0.6H). 13C NMR (125 MHz, CDCl3) (major and minor peaks reported) δ 91.2, 90.4, 74.7, 73.9, 66.8, 65.4, 58.1, 57.4, 54.0, 53.5, 53.2, 51.0, 42.6, 41.8, 28.4, 27.8, 23.6, 23.5, 23.3, 23.1, 20.8, 20.7, 16.8, 16.7. IR (thin film NaCl) 3035, 2969, 2873, 2813, 2242, 1462, 1444, 1400, 1368, 1319, 1180, 1123, 1095, 1067, 909 cm−1. HRMS (ESI) m/z 208.1695 [M+H; calcd for C13H21NO: 208.1696]. [α]D = −40.4 (23 °C, 589 nm, 0.2 g/100 mL, CHCl3).

Pumiliotoxin 209F (2)

In a glovebox, Ni(cod)2 (5.6 mg, 0.02 mmol) and PMe2Ph (5.7 μL, 0.04 mmol) were placed into an oven-dried, sealed tube, which was sealed with a rubber septum and teflon cap. The tube was removed from the glovebox, placed under argon, and triethylborane (22 μL, 0.15 mmol) was added via syringe. The resulting solution was stirred 5 min, and the epoxy-alkyne 3a (21 mg, 0.10 mmol) was added dropwise via microsyringe. The reaction was heated to 65 °C and allowed to stir 16 h. The solution was then cooled to rt, and ether (2 mL) was added to dilute the solution at which point the septum was removed and the reaction was stirred 30 min open to air to promote quenching of the catalyst. The crude mixture was purified by flash chromatography on silica gel using a solvent gradient (1:49 to 1:19 MeOH:CHCl3) to give pumiliotoxin 209F (2) as a colorless oil (14.6 mg, 70% yield, 1 diastereomer). Rf 0.33 (1:9 MeOH:CHCl3) 1H NMR (500 MHz, CDCl3) δ 5.11 (d, J = 9.2 Hz, 1H), 3.80 (d, J = 11.9 Hz, 1H), 3.07 (t, J = 8.3 Hz, 1H), 2.67 (s, 1H), 2.60–2.55 (m, 1H), 2.36 (d, J = 11.9 Hz, 1H), 2.24–2.20 (m, 1H), 2.12 (d, J = 13.8 Hz, 1H), 2.09 (d, J = 13.8 Hz, 1H), 1.98 (t, J = 5.0 Hz, 1H), 1.79–1.65 (m, 4H), 1.14 (s, 3H), 0.99 (d, J = 6.7 Hz, 3H), 0.92 (d, J = 6.7 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 135.8, 129.4, 71.9, 68.6, 54.6, 53.1, 48.9, 26.96, 24.5, 23.7, 23.6, 23.4, 21.3. IR (thin film NaCl) 3512, 2959, 2874, 2785, 2743, 1464, 1445, 1424, 1396, 1376, 1321, 1309, 1297, 1275, 1216, 1175, 1150, 1098, 967 cm−1. HRMS (ESI) m/z 210.1852 [M+H; calcd for C13H23NO: 210.1849]. [α]D = −12.8 (23 °C, 589 nm, 0.3 g/100 mL, CHCl3).

Pumiliotoxin 251 D (1)

Same experimental procedure as 2. Rf 0.30 (1:9 MeOH:CHCl3). 1H NMR (500 MHz, CDCl3) δ 5.04 (d, J = 9.5 Hz, 1H), 3.78 (d, J = 12.0 Hz, 1H), 3.07–3.03 (m, 1H), 2.67 (s, 1H), 2.42–2.30 (m, 1H), 2.34 (d, J = 12.0 Hz, 1H), 2.25–2.15 (m, 1H), 2.15–2.12 (m, 2H), 2.00–1.90 (m, 1H), 1.78–1.60 (m, 4H), 1.32–1.10 (m, 6H), 1.14 (s, 3H), 0.97 (d, J = 6.5 Hz, 3H), 0.87 (t, J = 6.9 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 134.7, 130.0, 71.8, 68.4, 54.7, 53.3, 48.9, 37.6, 32.2, 29.8, 24.4, 23.3, 22.9, 21.8, 21.2, 14.2. IR (thin film NaCl) 3418, 2982, 2909, 2872, 1660, 1465, 1420, 1324, 1305, 1291, 1176, 1121, 1072, 939, 913, 871 cm−1. HRMS (ESI) m/z 252.2321 [M+H; calcd for C16H29NO: 252.2322]. [α]D = −9.3 (23 °C, 589 nm, 0.05 g/100 mL, CHCl3).

Supplementary Material

Supporting Information

Scheme 2.

Scheme 2

Acknowledgments

This work was supported by the National Institutes of General Medical Sciences (GM-063755). We are grateful to Ms. Li Li for obtaining mass spectrometric data for all compounds (MIT Department of Chemistry Instrumentation Facility, which is supported in part by the NSF (Grants CHE-9809061 and DBI-9729592) and the NIH (Grant 1S10RR13886-01).

Footnotes

Supporting Information Available: Experimental procedures and full spectroscopic data for all new compounds. This material is available free of charge via the Internet at http://pubs.acs.org.

References

  • 1.Daly JW, Myers CW. Science. 1967;156:970–973. doi: 10.1126/science.156.3777.970. [DOI] [PubMed] [Google Scholar]
  • 2.For a recent review of pumiliotoxins, see: Daly JW, Spande TF, Garraffo HM. J Nat Prod. 2005;68:1556–1575. doi: 10.1021/np0580560.
  • 3.Daly JW, Tokuyama T, Fujiwara T, Highet RJ, Karle IL. J Am Chem Soc. 1980;102:830–836. [Google Scholar]
  • iv.For a review of pumiliotoxin syntheses, see: Franklin AS, Overman LE. Chem Rev. 1996;96:505–522. doi: 10.1021/cr950021p.
  • v.Total syntheses of pumiliotoxin 209F: Overman LE, Lesuisse D. Tetrahedron Lett. 1985;26:4167–4170.Kibayashi C, Aoyagi S. Synth Org Chem, Jpn. 1999;57:981–992.8-Epi-pumiliotoxin 209F: Sudau A, Münch W, Bats JW, Nubbemeyer U. Eur J Org Chem. 2002:3315–3325. doi: 10.1021/jo991484o.
  • vi.Total syntheses of pumiliotoxin 251D: Overman LE, Bell KL. J Am Chem Soc. 1981;103:1851–1853.Fox DNA, Lathbury D, Mahon MF, Molloy KC, Gallagher T. J Am Chem Soc. 1991;113:2652–2656.Racemic 251D: Bargar TM, Lett RM, Johnson PL, Hunter JE, Chang CP, Pernich DJ, Sabol MR, Dick MR. J Agric Food Chem. 1995;43:1044–1051.(d) See also ref. 5c.
  • vii.Formal syntheses of pumiliotoxins: Honda T, Hoshi M, Kanai K, Tsubuki M. J Chem Soc, Perkin Trans. 1994;I:2091–2101.Cossy J, Cases M, Pardo DG. Synlett. 1996:909–910.Barrett AGM, Damiani F. J Org Chem. 1999;64:1410–1411.Martin SF, Bur SK. Tetrahedron. 1999;55:8905–8914.Ni Y, Zhao G, Ding Y. J Chem Soc, Perkin Trans. 2000;1:3264–3266.Wang B, Fang K, Lin GQ. Tetrahedron Lett. 2003;44:7981–7984.
  • viii.Overman LE, Sharp MJ. Tetrahedron Lett. 1988;29:901–904. [Google Scholar]
  • ix.In the syntheses of several allopumiliotoxins, Montgomery utilized a diastereoselective nickel-catalyzed alkyne-aldehyde reductive cyclization to establish the (Z)-alkene and the configuration of a secondary alcohol: Tang XQ, Montgomery J. J Am Chem Soc. 1999;121:6098–6099.Tang XQ, Montgomery J. J Am Chem Soc. 2000;122:6950–6954.Review: Montgomery J. Angew Chem. 2004;43:3890–3908. doi: 10.1002/anie.200300634.
  • x.Molinaro C, Jamison TF. J Am Chem Soc. 2003;125:8076–8077. doi: 10.1021/ja0361401. [DOI] [PubMed] [Google Scholar]
  • xi.Molinaro C, Jamison TF. unpublished results. [Google Scholar]
  • xii.(a) Cbz-Pro methyl ester is commericially available. Alloc-Pro methyl ester was prepared in quantitative yield from Pro methyl ester and allyl chloroformate, see: Yamada Y, Takahashi W, Asada Y, Holiuchi J, Takeda K, Harigaya Y. Chem Pharm Bull. 2004;52:1082–1085. doi: 10.1248/cpb.52.1082.
  • xiii.Epimerization of ketones 4a and 4b was not observed (chiral GC analysis).
  • xiv.Corey EJ, Chaykovsky M. J Am Chem Soc. 1965;87:1353–1364. [Google Scholar]
  • xv.For a discussion on kinetic vs. thermodynamic control in sulfur ylide addition reactions, see: Johnson CR, Schroeck CW, Shanklin JR. J Am Chem Soc. 1973;95:7424–7431.
  • xvi.For a discussion on sulfur-ylide epoxidation of similar pyrrolidines, see: Fray MJ, Thomas EJ, Wallis JD. J Chem Soc, Perkin Trans. 1983;I:395–401.
  • xvii.For a discussion of substrate control in sulfur-ylide epoxidations, see Li H-H, Dai L-X, Aggarwal VK. Chem Rev. 1997;97:2341–2372. doi: 10.1021/cr960411r.and references cited therein.
  • xviii.Racemization could also be prevented by using less NaH (150 mol%) and by lowering the reaction temperature, but conversion to product was much slower. See Supporting Information for details.
  • xix.Genêt JP, Blart E, Savignac M, Lemeune S, Lemaire-Audoire S, Bernard JM. Synlett. 1993:680–682. [Google Scholar]
  • xx.Propargyl bromide 5a was prepared by treatment of 4-methylpent-2-yn-1-ol with CBr4 and PPh3 in CH2Cl2. See Supporting Information for details.
  • xxi.Other phosphine ligands evaluated include P(n-octyl)3, P(o-anisyl)3, P(CH2CH2CN)3, P(OEt)Ph2, P(OEt)2Ph, and P(OEt)3.
  • xxii.The cone angles of PBu3 and PMe2Ph are 132° and 122°, respectively: Rahman MM, Liu HY, Eriks K, Prock A, Giering WP. Organometallics. 1989;8:1–7.
  • xxiii.van Leeuwen PWNM, Kamer PCJ, Reek JNH, Dierkes P. Chem Rev. 2000;100:2741–2770. doi: 10.1021/cr9902704. [DOI] [PubMed] [Google Scholar]
  • xxiv.Preparation of bromide 5b: Okamoto S, Iwakubo M, Kobayashi K, Sato F. J Am Chem Soc. 1997;119:6984–6990.
  • xxv.Synthesis of aldehyde 9 in 56% yield over four steps: Goldstein SW, Overman LE, Rabinowitz MH. J Org Chem. 1992;57:1179–1190.
  • xxvi.Corey EJ, Fuchs PL. Tetrahedron Lett. 1972;13:3769–3772. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

RESOURCES